nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Mycophenolate mofetil—systemic lupus erythematosus	0.4	1	CbGbCtD
Raltegravir—UGT1A1—urine—systemic lupus erythematosus	0.0228	0.18	CbGeAlD
Raltegravir—CCR1—connective tissue—systemic lupus erythematosus	0.0154	0.122	CbGeAlD
Raltegravir—CCR1—cortex of kidney—systemic lupus erythematosus	0.0128	0.101	CbGeAlD
Raltegravir—UGT1A1—blood plasma—systemic lupus erythematosus	0.0119	0.094	CbGeAlD
Raltegravir—CCR1—lymphoid tissue—systemic lupus erythematosus	0.0113	0.089	CbGeAlD
Raltegravir—CCR1—tendon—systemic lupus erythematosus	0.0106	0.0837	CbGeAlD
Raltegravir—CCR1—bone marrow—systemic lupus erythematosus	0.0103	0.0811	CbGeAlD
Raltegravir—CCR1—lung—systemic lupus erythematosus	0.00929	0.0734	CbGeAlD
Raltegravir—CCR1—nervous system—systemic lupus erythematosus	0.00861	0.068	CbGeAlD
Raltegravir—CCR1—central nervous system—systemic lupus erythematosus	0.00829	0.0655	CbGeAlD
Raltegravir—UGT1A1—kidney—systemic lupus erythematosus	0.00539	0.0426	CbGeAlD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CXCL12—systemic lupus erythematosus	0.0033	0.0768	CbGpPWpGaD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CCR5—systemic lupus erythematosus	0.00226	0.0526	CbGpPWpGaD
Raltegravir—CCR1—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.00181	0.0421	CbGpPWpGaD
Raltegravir—CCR1—Chemokine receptors bind chemokines—CCL2—systemic lupus erythematosus	0.00173	0.0402	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—P2RY12—systemic lupus erythematosus	0.00156	0.0362	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.00144	0.0336	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.00124	0.0289	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.00124	0.0288	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CXCL12—systemic lupus erythematosus	0.00105	0.0244	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000942	0.0219	CbGpPWpGaD
Raltegravir—UGT1A1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000926	0.0215	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.000851	0.0198	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000834	0.0194	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000833	0.0194	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.000832	0.0194	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.00079	0.0184	CbGpPWpGaD
Raltegravir—UGT1A1—Phase II conjugation—NAT2—systemic lupus erythematosus	0.000735	0.0171	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.00073	0.017	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	0.000718	0.0167	CbGpPWpGaD
Raltegravir—CCR1—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.000702	0.0163	CbGpPWpGaD
Raltegravir—CCR1—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000666	0.0155	CbGpPWpGaD
Raltegravir—CCR1—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.000651	0.0151	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000634	0.0148	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000571	0.0133	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000558	0.013	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000533	0.0124	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00049	0.0114	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000484	0.0113	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000436	0.0102	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000435	0.0101	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—NAT2—systemic lupus erythematosus	0.00043	0.01	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—C3—systemic lupus erythematosus	0.000425	0.00988	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000424	0.00987	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—F2—systemic lupus erythematosus	0.000373	0.00868	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	0.000359	0.00835	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000358	0.00834	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000334	0.00778	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000332	0.00773	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	0.000326	0.00758	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000325	0.00757	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	0.000319	0.00742	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000304	0.00706	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000295	0.00686	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	0.000286	0.00666	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000286	0.00665	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000275	0.0064	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.00027	0.00628	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CSK—systemic lupus erythematosus	0.000263	0.00612	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000259	0.00603	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	0.000249	0.00579	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000246	0.00572	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000242	0.00563	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—RXRA—systemic lupus erythematosus	0.000241	0.00561	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NCF2—systemic lupus erythematosus	0.00024	0.0056	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—C3—systemic lupus erythematosus	0.00024	0.00559	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LYN—systemic lupus erythematosus	0.000239	0.00556	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000235	0.00548	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000234	0.00545	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	0.000232	0.0054	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000223	0.00519	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.00022	0.00512	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—C3—systemic lupus erythematosus	0.000218	0.00507	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000211	0.0049	CbGpPWpGaD
Raltegravir—Hypertension—Betamethasone—systemic lupus erythematosus	0.000195	0.000453	CcSEcCtD
Raltegravir—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000195	0.000453	CcSEcCtD
Raltegravir—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000193	0.00045	CcSEcCtD
Raltegravir—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000193	0.00045	CcSEcCtD
Raltegravir—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000193	0.000448	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000192	0.00447	CbGpPWpGaD
Raltegravir—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000192	0.000446	CcSEcCtD
Raltegravir—Myalgia—Betamethasone—systemic lupus erythematosus	0.000192	0.000446	CcSEcCtD
Raltegravir—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000192	0.000445	CcSEcCtD
Raltegravir—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000192	0.000445	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—F2—systemic lupus erythematosus	0.000191	0.00445	CbGpPWpGaD
Raltegravir—Anxiety—Betamethasone—systemic lupus erythematosus	0.000191	0.000445	CcSEcCtD
Raltegravir—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000191	0.000445	CcSEcCtD
Raltegravir—Discomfort—Dexamethasone—systemic lupus erythematosus	0.00019	0.000441	CcSEcCtD
Raltegravir—Discomfort—Betamethasone—systemic lupus erythematosus	0.00019	0.000441	CcSEcCtD
Raltegravir—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.00019	0.000441	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000189	0.00439	CbGpPWpGaD
Raltegravir—Pain—Prednisolone—systemic lupus erythematosus	0.000189	0.000439	CcSEcCtD
Raltegravir—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000189	0.000438	CcSEcCtD
Raltegravir—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.000437	CcSEcCtD
Raltegravir—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000187	0.000435	CcSEcCtD
Raltegravir—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000187	0.000435	CcSEcCtD
Raltegravir—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000187	0.000435	CcSEcCtD
Raltegravir—Nausea—Leflunomide—systemic lupus erythematosus	0.000187	0.000434	CcSEcCtD
Raltegravir—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000186	0.000433	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000186	0.000432	CcSEcCtD
Raltegravir—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000186	0.000432	CcSEcCtD
Raltegravir—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000185	0.00043	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000185	0.00043	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000184	0.000429	CcSEcCtD
Raltegravir—Pain—Hydrocortisone—systemic lupus erythematosus	0.000184	0.000428	CcSEcCtD
Raltegravir—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000183	0.000427	CcSEcCtD
Raltegravir—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000183	0.000426	CcSEcCtD
Raltegravir—Infection—Dexamethasone—systemic lupus erythematosus	0.000183	0.000425	CcSEcCtD
Raltegravir—Infection—Betamethasone—systemic lupus erythematosus	0.000183	0.000425	CcSEcCtD
Raltegravir—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000182	0.000424	CcSEcCtD
Raltegravir—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000182	0.000423	CcSEcCtD
Raltegravir—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000182	0.000423	CcSEcCtD
Raltegravir—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000182	0.000423	CcSEcCtD
Raltegravir—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000182	0.000422	CcSEcCtD
Raltegravir—Anaemia—Prednisone—systemic lupus erythematosus	0.000182	0.000422	CcSEcCtD
Raltegravir—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000181	0.00042	CcSEcCtD
Raltegravir—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000181	0.00042	CcSEcCtD
Raltegravir—Agitation—Prednisone—systemic lupus erythematosus	0.00018	0.00042	CcSEcCtD
Raltegravir—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.00018	0.000419	CcSEcCtD
Raltegravir—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.00018	0.000419	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000179	0.00417	CbGpPWpGaD
Raltegravir—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000179	0.000415	CcSEcCtD
Raltegravir—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000179	0.000415	CcSEcCtD
Raltegravir—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000178	0.000414	CcSEcCtD
Raltegravir—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000178	0.000414	CcSEcCtD
Raltegravir—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000178	0.000414	CcSEcCtD
Raltegravir—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000178	0.000414	CcSEcCtD
Raltegravir—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000178	0.000413	CcSEcCtD
Raltegravir—Malaise—Prednisone—systemic lupus erythematosus	0.000177	0.000412	CcSEcCtD
Raltegravir—Vertigo—Prednisone—systemic lupus erythematosus	0.000176	0.00041	CcSEcCtD
Raltegravir—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000176	0.00041	CcSEcCtD
Raltegravir—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000176	0.00041	CcSEcCtD
Raltegravir—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000176	0.000409	CcSEcCtD
Raltegravir—Urticaria—Prednisolone—systemic lupus erythematosus	0.000175	0.000407	CcSEcCtD
Raltegravir—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000175	0.000407	CcSEcCtD
Raltegravir—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000175	0.000407	CcSEcCtD
Raltegravir—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000175	0.000406	CcSEcCtD
Raltegravir—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000174	0.000405	CcSEcCtD
Raltegravir—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000174	0.000404	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PRL—systemic lupus erythematosus	0.000174	0.00405	CbGpPWpGaD
Raltegravir—Pain—Triamcinolone—systemic lupus erythematosus	0.000173	0.000403	CcSEcCtD
Raltegravir—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000172	0.000399	CcSEcCtD
Raltegravir—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000171	0.000398	CcSEcCtD
Raltegravir—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000171	0.000398	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000171	0.00397	CbGpPWpGaD
Raltegravir—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.00017	0.000396	CcSEcCtD
Raltegravir—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00017	0.000396	CcSEcCtD
Raltegravir—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.00017	0.000396	CcSEcCtD
Raltegravir—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.00017	0.000395	CcSEcCtD
Raltegravir—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00017	0.000394	CcSEcCtD
Raltegravir—Hypertension—Prednisone—systemic lupus erythematosus	0.00017	0.000394	CcSEcCtD
Raltegravir—Chills—Methotrexate—systemic lupus erythematosus	0.000169	0.000393	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000168	0.00039	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000168	0.00039	CcSEcCtD
Raltegravir—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000167	0.000389	CcSEcCtD
Raltegravir—Myalgia—Prednisone—systemic lupus erythematosus	0.000167	0.000389	CcSEcCtD
Raltegravir—Arthralgia—Prednisone—systemic lupus erythematosus	0.000167	0.000389	CcSEcCtD
Raltegravir—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000167	0.000389	CcSEcCtD
Raltegravir—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000167	0.000388	CcSEcCtD
Raltegravir—Anxiety—Prednisone—systemic lupus erythematosus	0.000167	0.000387	CcSEcCtD
Raltegravir—Alopecia—Methotrexate—systemic lupus erythematosus	0.000167	0.000387	CcSEcCtD
Raltegravir—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000166	0.000387	CcSEcCtD
Raltegravir—Insomnia—Betamethasone—systemic lupus erythematosus	0.000166	0.000387	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000166	0.000386	CcSEcCtD
Raltegravir—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000166	0.000386	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000166	0.000385	CcSEcCtD
Raltegravir—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000165	0.000384	CcSEcCtD
Raltegravir—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000165	0.000384	CcSEcCtD
Raltegravir—Discomfort—Prednisone—systemic lupus erythematosus	0.000165	0.000384	CcSEcCtD
Raltegravir—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000165	0.000384	CcSEcCtD
Raltegravir—Erythema—Methotrexate—systemic lupus erythematosus	0.000164	0.000382	CcSEcCtD
Raltegravir—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000164	0.000382	CcSEcCtD
Raltegravir—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000163	0.000378	CcSEcCtD
Raltegravir—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000162	0.000377	CcSEcCtD
Raltegravir—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000162	0.000377	CcSEcCtD
Raltegravir—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000162	0.000376	CcSEcCtD
Raltegravir—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000161	0.000375	CcSEcCtD
Raltegravir—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000161	0.000374	CcSEcCtD
Raltegravir—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000161	0.000374	CcSEcCtD
Raltegravir—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.00016	0.000373	CcSEcCtD
Raltegravir—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00016	0.000373	CcSEcCtD
Raltegravir—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.00016	0.000372	CcSEcCtD
Raltegravir—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.00016	0.000372	CcSEcCtD
Raltegravir—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.00016	0.000372	CcSEcCtD
Raltegravir—Infection—Prednisone—systemic lupus erythematosus	0.000159	0.00037	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000159	0.000369	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000159	0.000369	CcSEcCtD
Raltegravir—Back pain—Methotrexate—systemic lupus erythematosus	0.000159	0.000369	CcSEcCtD
Raltegravir—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000159	0.000369	CcSEcCtD
Raltegravir—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000159	0.000369	CcSEcCtD
Raltegravir—Fatigue—Betamethasone—systemic lupus erythematosus	0.000159	0.000369	CcSEcCtD
Raltegravir—Pain—Dexamethasone—systemic lupus erythematosus	0.000157	0.000366	CcSEcCtD
Raltegravir—Pain—Betamethasone—systemic lupus erythematosus	0.000157	0.000366	CcSEcCtD
Raltegravir—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000157	0.000365	CcSEcCtD
Raltegravir—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000156	0.000364	CcSEcCtD
Raltegravir—Skin disorder—Prednisone—systemic lupus erythematosus	0.000156	0.000362	CcSEcCtD
Raltegravir—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000155	0.00036	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000155	0.0036	CbGpPWpGaD
Raltegravir—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000155	0.000359	CcSEcCtD
Raltegravir—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000154	0.000358	CcSEcCtD
Raltegravir—Rash—Cyclosporine—systemic lupus erythematosus	0.000153	0.000355	CcSEcCtD
Raltegravir—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000153	0.000355	CcSEcCtD
Raltegravir—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000152	0.000354	CcSEcCtD
Raltegravir—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000152	0.000354	CcSEcCtD
Raltegravir—Headache—Cyclosporine—systemic lupus erythematosus	0.000152	0.000353	CcSEcCtD
Raltegravir—Anaemia—Methotrexate—systemic lupus erythematosus	0.000152	0.000353	CcSEcCtD
Raltegravir—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000152	0.000353	CcSEcCtD
Raltegravir—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000152	0.000353	CcSEcCtD
Raltegravir—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000151	0.00035	CcSEcCtD
Raltegravir—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000151	0.00035	CcSEcCtD
Raltegravir—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.00015	0.00035	CcSEcCtD
Raltegravir—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000149	0.000347	CcSEcCtD
Raltegravir—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000149	0.000347	CcSEcCtD
Raltegravir—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.000347	CcSEcCtD
Raltegravir—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.000346	CcSEcCtD
Raltegravir—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000148	0.000344	CcSEcCtD
Raltegravir—Malaise—Methotrexate—systemic lupus erythematosus	0.000148	0.000344	CcSEcCtD
Raltegravir—Vertigo—Methotrexate—systemic lupus erythematosus	0.000147	0.000343	CcSEcCtD
Raltegravir—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000147	0.000343	CcSEcCtD
Raltegravir—Urticaria—Betamethasone—systemic lupus erythematosus	0.000146	0.00034	CcSEcCtD
Raltegravir—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000146	0.00034	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000146	0.00034	CcSEcCtD
Raltegravir—Dizziness—Prednisolone—systemic lupus erythematosus	0.000146	0.000339	CcSEcCtD
Raltegravir—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000146	0.000338	CcSEcCtD
Raltegravir—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000146	0.000338	CcSEcCtD
Raltegravir—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000146	0.000338	CcSEcCtD
Raltegravir—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000146	0.000338	CcSEcCtD
Raltegravir—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000146	0.000338	CcSEcCtD
Raltegravir—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000145	0.000338	CcSEcCtD
Raltegravir—Insomnia—Prednisone—systemic lupus erythematosus	0.000145	0.000337	CcSEcCtD
Raltegravir—Nausea—Cyclosporine—systemic lupus erythematosus	0.000144	0.000335	CcSEcCtD
Raltegravir—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000144	0.000335	CcSEcCtD
Raltegravir—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000144	0.000334	CcSEcCtD
Raltegravir—Cough—Methotrexate—systemic lupus erythematosus	0.000143	0.000333	CcSEcCtD
Raltegravir—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000143	0.000333	CcSEcCtD
Raltegravir—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000142	0.000331	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000142	0.0033	CbGpPWpGaD
Raltegravir—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000141	0.000328	CcSEcCtD
Raltegravir—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.00014	0.000327	CcSEcCtD
Raltegravir—Arthralgia—Methotrexate—systemic lupus erythematosus	0.00014	0.000325	CcSEcCtD
Raltegravir—Chest pain—Methotrexate—systemic lupus erythematosus	0.00014	0.000325	CcSEcCtD
Raltegravir—Myalgia—Methotrexate—systemic lupus erythematosus	0.00014	0.000325	CcSEcCtD
Raltegravir—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000139	0.000324	CcSEcCtD
Raltegravir—Rash—Prednisolone—systemic lupus erythematosus	0.000139	0.000323	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000139	0.00324	CbGpPWpGaD
Raltegravir—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000139	0.000323	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000139	0.000323	CcSEcCtD
Raltegravir—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000138	0.000322	CcSEcCtD
Raltegravir—Fatigue—Prednisone—systemic lupus erythematosus	0.000138	0.000321	CcSEcCtD
Raltegravir—Headache—Prednisolone—systemic lupus erythematosus	0.000138	0.000321	CcSEcCtD
Raltegravir—Discomfort—Methotrexate—systemic lupus erythematosus	0.000138	0.000321	CcSEcCtD
Raltegravir—Constipation—Prednisone—systemic lupus erythematosus	0.000137	0.000319	CcSEcCtD
Raltegravir—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000137	0.000318	CcSEcCtD
Raltegravir—Rash—Hydrocortisone—systemic lupus erythematosus	0.000136	0.000316	CcSEcCtD
Raltegravir—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000136	0.000315	CcSEcCtD
Raltegravir—Confusional state—Methotrexate—systemic lupus erythematosus	0.000135	0.000314	CcSEcCtD
Raltegravir—Headache—Hydrocortisone—systemic lupus erythematosus	0.000135	0.000314	CcSEcCtD
Raltegravir—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000134	0.000312	CcSEcCtD
Raltegravir—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000134	0.000311	CcSEcCtD
Raltegravir—Infection—Methotrexate—systemic lupus erythematosus	0.000133	0.000309	CcSEcCtD
Raltegravir—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000132	0.000307	CcSEcCtD
Raltegravir—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000132	0.000307	CcSEcCtD
Raltegravir—Asthenia—Betamethasone—systemic lupus erythematosus	0.000132	0.000307	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000132	0.00307	CbGpPWpGaD
Raltegravir—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000131	0.000305	CcSEcCtD
Raltegravir—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000131	0.000305	CcSEcCtD
Raltegravir—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000131	0.000305	CcSEcCtD
Raltegravir—Nausea—Prednisolone—systemic lupus erythematosus	0.000131	0.000305	CcSEcCtD
Raltegravir—Pruritus—Betamethasone—systemic lupus erythematosus	0.00013	0.000303	CcSEcCtD
Raltegravir—Pruritus—Dexamethasone—systemic lupus erythematosus	0.00013	0.000303	CcSEcCtD
Raltegravir—Skin disorder—Methotrexate—systemic lupus erythematosus	0.00013	0.000303	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.00013	0.00302	CbGpPWpGaD
Raltegravir—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.00013	0.000301	CcSEcCtD
Raltegravir—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000129	0.0003	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000129	0.003	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—C3—systemic lupus erythematosus	0.000129	0.003	CbGpPWpGaD
Raltegravir—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000129	0.000299	CcSEcCtD
Raltegravir—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000128	0.000297	CcSEcCtD
Raltegravir—Rash—Triamcinolone—systemic lupus erythematosus	0.000128	0.000297	CcSEcCtD
Raltegravir—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000128	0.000297	CcSEcCtD
Raltegravir—Rash—Methylprednisolone—systemic lupus erythematosus	0.000128	0.000297	CcSEcCtD
Raltegravir—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000128	0.000296	CcSEcCtD
Raltegravir—Urticaria—Prednisone—systemic lupus erythematosus	0.000127	0.000296	CcSEcCtD
Raltegravir—Headache—Triamcinolone—systemic lupus erythematosus	0.000127	0.000295	CcSEcCtD
Raltegravir—Headache—Methylprednisolone—systemic lupus erythematosus	0.000127	0.000295	CcSEcCtD
Raltegravir—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000127	0.000295	CcSEcCtD
Raltegravir—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000127	0.000295	CcSEcCtD
Raltegravir—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000126	0.000293	CcSEcCtD
Raltegravir—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000126	0.000293	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000122	0.000284	CcSEcCtD
Raltegravir—Dizziness—Betamethasone—systemic lupus erythematosus	0.000122	0.000283	CcSEcCtD
Raltegravir—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000122	0.000283	CcSEcCtD
Raltegravir—Insomnia—Methotrexate—systemic lupus erythematosus	0.000121	0.000282	CcSEcCtD
Raltegravir—Nausea—Triamcinolone—systemic lupus erythematosus	0.00012	0.00028	CcSEcCtD
Raltegravir—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.00012	0.00028	CcSEcCtD
Raltegravir—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00012	0.000279	CcSEcCtD
Raltegravir—Somnolence—Methotrexate—systemic lupus erythematosus	0.000119	0.000277	CcSEcCtD
Raltegravir—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000118	0.000275	CcSEcCtD
Raltegravir—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000118	0.000274	CcSEcCtD
Raltegravir—Vomiting—Betamethasone—systemic lupus erythematosus	0.000117	0.000272	CcSEcCtD
Raltegravir—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000117	0.000272	CcSEcCtD
Raltegravir—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000116	0.000271	CcSEcCtD
Raltegravir—Rash—Betamethasone—systemic lupus erythematosus	0.000116	0.00027	CcSEcCtD
Raltegravir—Rash—Dexamethasone—systemic lupus erythematosus	0.000116	0.00027	CcSEcCtD
Raltegravir—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000116	0.00027	CcSEcCtD
Raltegravir—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000116	0.00027	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000116	0.000269	CcSEcCtD
Raltegravir—Fatigue—Methotrexate—systemic lupus erythematosus	0.000115	0.000269	CcSEcCtD
Raltegravir—Headache—Betamethasone—systemic lupus erythematosus	0.000115	0.000268	CcSEcCtD
Raltegravir—Headache—Dexamethasone—systemic lupus erythematosus	0.000115	0.000268	CcSEcCtD
Raltegravir—Asthenia—Prednisone—systemic lupus erythematosus	0.000115	0.000267	CcSEcCtD
Raltegravir—Pain—Methotrexate—systemic lupus erythematosus	0.000115	0.000266	CcSEcCtD
Raltegravir—Pruritus—Prednisone—systemic lupus erythematosus	0.000113	0.000264	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—F2—systemic lupus erythematosus	0.000113	0.00263	CbGpPWpGaD
Raltegravir—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.00011	0.000257	CcSEcCtD
Raltegravir—Diarrhoea—Prednisone—systemic lupus erythematosus	0.00011	0.000255	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.00011	0.000255	CcSEcCtD
Raltegravir—Nausea—Betamethasone—systemic lupus erythematosus	0.000109	0.000254	CcSEcCtD
Raltegravir—Nausea—Dexamethasone—systemic lupus erythematosus	0.000109	0.000254	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CD80—systemic lupus erythematosus	0.000108	0.00252	CbGpPWpGaD
Raltegravir—Urticaria—Methotrexate—systemic lupus erythematosus	0.000106	0.000247	CcSEcCtD
Raltegravir—Dizziness—Prednisone—systemic lupus erythematosus	0.000106	0.000246	CcSEcCtD
Raltegravir—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000106	0.000246	CcSEcCtD
Raltegravir—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000106	0.000246	CcSEcCtD
Raltegravir—Vomiting—Prednisone—systemic lupus erythematosus	0.000102	0.000237	CcSEcCtD
Raltegravir—Rash—Prednisone—systemic lupus erythematosus	0.000101	0.000235	CcSEcCtD
Raltegravir—Dermatitis—Prednisone—systemic lupus erythematosus	0.000101	0.000235	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000101	0.00234	CbGpPWpGaD
Raltegravir—Headache—Prednisone—systemic lupus erythematosus	0.0001	0.000233	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—TGFB1—systemic lupus erythematosus	9.87e-05	0.0023	CbGpPWpGaD
Raltegravir—Hypersensitivity—Methotrexate—systemic lupus erythematosus	9.87e-05	0.000229	CcSEcCtD
Raltegravir—Asthenia—Methotrexate—systemic lupus erythematosus	9.61e-05	0.000223	CcSEcCtD
Raltegravir—Nausea—Prednisone—systemic lupus erythematosus	9.52e-05	0.000221	CcSEcCtD
Raltegravir—Pruritus—Methotrexate—systemic lupus erythematosus	9.48e-05	0.00022	CcSEcCtD
Raltegravir—Diarrhoea—Methotrexate—systemic lupus erythematosus	9.17e-05	0.000213	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—TYK2—systemic lupus erythematosus	9.15e-05	0.00213	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NOS3—systemic lupus erythematosus	8.98e-05	0.00209	CbGpPWpGaD
Raltegravir—Dizziness—Methotrexate—systemic lupus erythematosus	8.86e-05	0.000206	CcSEcCtD
Raltegravir—Vomiting—Methotrexate—systemic lupus erythematosus	8.52e-05	0.000198	CcSEcCtD
Raltegravir—Rash—Methotrexate—systemic lupus erythematosus	8.45e-05	0.000196	CcSEcCtD
Raltegravir—Dermatitis—Methotrexate—systemic lupus erythematosus	8.44e-05	0.000196	CcSEcCtD
Raltegravir—Headache—Methotrexate—systemic lupus erythematosus	8.39e-05	0.000195	CcSEcCtD
Raltegravir—Nausea—Methotrexate—systemic lupus erythematosus	7.96e-05	0.000185	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.78e-05	0.00181	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL2—systemic lupus erythematosus	7.61e-05	0.00177	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6—systemic lupus erythematosus	7.58e-05	0.00176	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NAT2—systemic lupus erythematosus	7.35e-05	0.00171	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MMP9—systemic lupus erythematosus	7.21e-05	0.00168	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	7.18e-05	0.00167	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EP300—systemic lupus erythematosus	6.83e-05	0.00159	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.47e-05	0.00151	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.94e-05	0.00138	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6—systemic lupus erythematosus	4.47e-05	0.00104	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—RXRA—systemic lupus erythematosus	4.12e-05	0.000959	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARG—systemic lupus erythematosus	2.6e-05	0.000606	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALB—systemic lupus erythematosus	2.34e-05	0.000545	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NOS3—systemic lupus erythematosus	2.24e-05	0.000521	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTGS2—systemic lupus erythematosus	2.05e-05	0.000477	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—EP300—systemic lupus erythematosus	1.7e-05	0.000396	CbGpPWpGaD
